Mushlih Y, Suryoadji KA, Prasetyawaty F. Survival Rate of Gemcitabine Monotherapy after Prior Platinum-based Chemotherapy for Metastatic Bladder Cancer. Cermin Dunia Kedokteran [Internet]. 2022 Dec. 1 [cited 2024 Oct. 30];49(12):693-701. Available from: https://cdkjournal.com/index.php/cdk/article/view/329